Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT00014456
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed advanced solid tumor that is not curable by surgery or radiotherapy
* Sarcoma
* Melanoma
* Carcinoma of unknown primary
* Pancreatic cancer
* Lung cancer
* Ovarian cancer
* Breast cancer
* Bladder cancer
* Gastric cancer
* Esophageal cancer
* Prostate cancer
* Head and neck cancer
* No hematopoietic or lymphoid tumors
* Measurable or evaluable disease
PATIENT CHARACTERISTICS:
Age:
* Over 18
Performance status:
* Karnofsky 60-100%
* ECOG 0-2
Life expectancy:
* Not specified
Hematopoietic:
* Absolute neutrophil count greater than 1,000/mm\^3
* Platelet count greater than 100,000/mm\^3
Hepatic:
* Bilirubin normal
* AST and/or ALT no greater than 5 times upper limit of normal (ULN) if alkaline phosphatase no greater than ULN OR
* Alkaline phosphatase no greater than 5 times ULN if AST and ALT no greater than ULN OR
* AST and/or ALT no greater than 1.5 times ULN if alkaline phosphatase no greater than 2.5 times ULN
Renal:
* Creatinine no greater than 2 times ULN OR
* Creatinine clearance at least 50 mL/min
Cardiovascular:
* No congestive heart failure
* No unstable angina
Other:
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* No uncontrolled infection
* No known sensitivity to E. coli-derived products
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* At least 2 weeks since prior cytotoxic anti-tumor therapy (4 weeks for nitrosourea or mitomycin) and recovered
* No prior docetaxel or gemcitabine
Endocrine therapy:
* Not specified
Radiotherapy:
* See Disease Characteristics
* At least 2 weeks since prior radiotherapy and recovered
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00014456
Study Brief:
Protocol Section:
NCT00014456